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Figure 1. Turquoise killifi sh and its habitat.
Seasonal savannah pools retain water for only a few months (top left), giving turquoise killifi sh 
limited time to complete their life cycle. In less than three weeks, females (top right) develop ripe 
eggs. Males exist in two discrete colour morphs, with a red (bottom right) or yellow (bottom left) 
caudal fi n. Photo credits: Martin Reichard (top left), and Radim Blažek.Do they also age faster? Certainly. 
In the few months that they live, 
they display cellular and molecular 
changes comparable to those 
observed in ageing humans over 
several decades, developing learning 
impairments, heart lesions, pigment 
change and even tumours. For these 
reasons, they have been used to 
test the effects of diet and drugs on 
ageing and longevity.
Are there any resources available 
to experimental biologists? 
Despite being a recently adopted 
model taxon, there are already many 
resources for genetic studies on 
turquoise killifi sh. There is an inbred 
strain and a number of wild-derived 
strains that differ in their lifespan and 
other phenotypic traits. The genome 
has recently been sequenced, 
assembled and annotated, and some 
chromosomal regions responsible 
for phenotypic differences among 
strains identifi ed. Transgenesis has 
been developed, permitting the 
manipulation of the killifi sh genome, 
and genome-editing techniques 
have even introduced human point 
mutations into its genes. With 
growing understanding of the ecology 
of wild populations on one hand, R742 Current Biology 25, R733–R752, Auguand of the biological mechanisms 
associated with short lifespan 
and rapid ageing on the other, the 
turquoise killifi sh offers a tractable 
system for integrating conceptual 
and methodological insights from 
ecological and biomedical research.
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Our cognitive abilities emerge from 
the coordinated activity of neurons in 
the brain. The average human brain 
contains 86 billion neurons that are 
richly interconnected through synapses, 
contact points for electrochemical 
communication. Patterns of synaptic 
connectivity create functional 
ensembles of neurons, called neural 
circuits, which mediate information 
processing in the brain. Neural circuits 
can be deconstructed further into 
basic motifs (‘microcircuits’) involving 
feedforward and feedback connections 
between different types of neurons that 
exert excitatory or inhibitory infl uence. 
At each level of neural circuitry, the 
opposing forces of excitation and 
inhibition are normally held in balance 
through a variety of homeostatic 
mechanisms.
Epileptic seizures — the paroxysmal 
symptoms and signs related to 
excessive electrical activity in the 
brain — are a common clinical 
expression of neural circuit dysfunction. 
Seizures can result from myriad 
brain pathologies, and the protean 
manifestations of seizures relate to the 
fact that they can arise from any region 
of the cerebral cortex. Epilepsy is the 
clinical condition characterized by a 
chronic predisposition to spontaneous 
seizures. Affecting 0.5–1% of the 
world’s population, epilepsy is 
associated with considerable somatic 
and psychosocial morbidity as well 
as increased mortality. Despite the 
global burden of epilepsy, however, 
the pathogenesis of seizures remains 
poorly understood.
Hypersynchrony
A canonical view holds that 
seizures result when an imbalance 
between excitation and inhibition 
produces runaway excitation and 
‘hypersynchrony’ within neural circuits. 
Synchrony in this context is loosely 
defi ned as large numbers of neurons 
fi ring action potentials in unison. 
Conceptualization of seizures as a 
homogeneous, unbridled alliance of 
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Figure 1. Scalp EEG recording of a focal seizure. 
High-amplitude, rhythmic waveforms (box) arise from electrodes overlying the right temporal 
lobe. Clinically, the patient experienced a rising epigastric sensation and déjà vu before becoming 
 confused, features typical of temporal lobe seizures.excitatory neurons marching in step 
has dominated thinking in the fi eld 
for decades. This model has been 
fruitful, leading to the development 
of many antiepileptic drugs that blunt 
excitation or enhance inhibition. 
Hypersynchronous neuronal fi ring 
is also thought to underlie high-
amplitude voltage changes recorded by 
electroencephalography (EEG) during 
seizures (Figure 1).
Still, steady-state imbalance between 
cortical excitation and inhibition 
has been diffi cult to demonstrate in 
experimental models of epilepsy and 
would not explain the infrequent, 
episodic nature of most seizures. Many 
causal genetic mutations that have 
been identifi ed in epilepsy are not 
predicted to directly affect neuronal 
excitability. Recent recordings of 
population neuronal activity during 
seizures challenge the historical 
formulation of hypersynchrony during 
seizures and suggest that the prevailing 
model may be oversimplifi ed. 
The motivation to address 
defi ciencies in our mechanistic 
understanding of epilepsy is enormous. 
Over 30% of patients with epilepsy 
have seizures that cannot be fully 
controlled with medications, and even 
patients who are well-controlled suffer 
side effects from their medications. For 
some drug-resistant patients, surgical 
resection of seizure-producing neural 
tissue can be an effective treatment, 
but success in this approach hinges 
on accurate analysis of EEG signals 
to localize seizure onset. The rules 
governing seizure initiation and 
termination are largely unknown, and 
reliable seizure prediction strategies 
remain elusive. An ever-increasing 
wealth of human genetic information 
requires interpretation of molecular 
lesions in the context of neural circuit 
dysfunction.
Circuits
A clinical and electrographic hallmark 
of seizures is their evolution: seizures 
generally have a beginning, a middle, 
and an end. To what extent is this 
property refl ected at the level of 
neuronal physiology? 
Recently, the behavior of individual 
neurons during seizures has been 
characterized using microelectrode 
arrays placed directly on the brain 
surface in patients undergoing Curintracranial monitoring for seizure 
localization. By capturing the activity 
of single neurons, microelectrode 
recordings avoid the loss of 
information intrinsic to macroscopic 
EEG-based recordings that average 
the activity of many thousands of 
neurons. What has emerged from 
these studies is a new picture in 
which seizures result from a complex 
interplay between various types of 
neurons whose degree of synchrony 
is dynamic and evolves on multiple 
spatial and temporal scales. 
Brain tissue affected by seizures can 
be spatially segregated into a central 
‘core’ and a surrounding ‘penumbra’ 
that are demarcated by sharply 
diverging patterns of neuronal activity 
(Figure 2). Activity in the seizure core is 
characterized by intense, synchronous 
neuronal fi ring, whereas activity in 
the penumbra demonstrates low-
level, unstructured, desynchronized 
neuronal fi ring. This center–surround 
pattern is thought to be established 
by feedforward inhibitory projections 
emanating from neural circuits that are 
recruited to the seizure core. These 
inhibitory projections create strong 
postsynaptic currents in penumbral 
tissue that limit expansion of the seizure 
core and serve as an endogenous 
restraint on ictal (relating to a seizure) 
propagation. Because summated 
postsynaptic potentials form the 
basis of signals recorded by EEG, the rent Biology 25, R733–R752, August 31, 2015defi ning feature of the penumbra is 
a dissociation between low rates of 
neuronal spiking and high-amplitude 
EEG signals. This new concept has 
signifi cant implications for epilepsy 
surgery: the area of brain tissue 
demonstrating ictal EEG changes is 
considerably larger than the seizure 
core and resection of penumbral 
tissue may increase post-operative 
neurological defi cits without improving 
seizure control. 
Biomarkers
A candidate biomarker to distinguish 
the seizure core from surrounding 
penumbra is high-frequency 
oscillations. Defi ned as fi eld potential 
oscillations whose frequency exceeds 
80 Hz, high-frequency oscillations 
can be recorded using high-sampling 
rate scalp and intracranial EEG in 
the normal human brain, particularly 
during sleep. Though controversial, 
a large body of work suggests that 
so-called ‘pathological high-frequency 
oscillations’ are also tightly associated 
with the seizure onset zone. 
Specifi cally, recent studies have 
revealed that high gamma frequency 
band (80–150 Hz) high-frequency 
oscillations that are phase-locked to 
lower-frequency ictal rhythms reliably 
identify the seizure core and distinguish 
it from surrounding penumbra. Using 
this electrophysiological criterion, the 
seizure core is far smaller than territory  ©2015 Elsevier Ltd All rights reserved R743
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Figure 2. Intracranial EEG recording demonstrating onset and spread of a seizure.
(A) Seizure activity arises focally and propagates across an array of electrodes placed directly 
on the brain surface. (B) Three-dimensional reconstruction of implanted electrodes covering the 
left cerebral hemisphere. Superimposed heatmap indicates seizure onset zone as determined by 
intracranial EEG. (C) The seizure onset zone is conceptualized as a core of intense, hypersynchro-
nous neuronal fi ring surrounded by an inhibitory penumbra with desynchronized neuronal fi ring 
that restrains seizure propagation.identifi ed as being involved in the 
seizure by EEG. 
Preliminary analyses of epilepsy 
surgery outcomes indicate that 
resection of phase-locked high gamma 
sites correlates with the extent of 
post-operative seizure freedom. This 
metric is not yet widely incorporated 
into surgical planning, in part because 
it remains unclear how generalizable 
the association between phase-locked 
high gamma and the seizure onset zone 
is across different types of seizures. 
Indeed, although the source of high-
frequency oscillations at a network 
level remains unclear, it is thought 
that high-frequency oscillation rates 
depend on the nature of the underlying 
epileptogenic lesion. 
Microseizures
In addition to spatial heterogeneity, 
neuronal activity demonstrates 
temporal heterogeneity during seizures. 
Recently, electrographic seizure-like 
discharges have been observed at 
single microelectrodes, suggesting 
that they arise from small neuronal R744 Current Biology 25, R733–R752, Auguclusters. Termed ‘microseizures’, 
these subclinical events may refl ect 
pathological hyperexcitability within a 
small number of adjacent microcircuits. 
An emerging model of seizure 
initiation portrays seizures as 
developing from coalescence of 
multifocal, initially asynchronous 
epileptic microdomains. This model 
explains the otherwise counterintuitive 
observation that the pre-ictal period 
and early stages of seizures are actually 
characterized by desynchronization, 
followed by increasing macroscale 
synchronization as the seizure 
progresses. As microdomain 
recruitment reaches critical mass 
(forming a seizure core), feedforward 
inhibition also progresses, creating 
the penumbra that restrains further 
propagation. 
Equilibrium between core and 
penumbra may be the physiological 
correlate of focal or ‘localization-related’ 
seizures for which clinical symptoms — 
sensorimotor, visual, dyscognitive, 
and so on — depend on the cortical 
territories involved in the core (and st 31, 2015 ©2015 Elsevier Ltd All rights reserveperhaps the penumbra). Focal seizures 
that propagate to involve broader 
cortical regions presumably result from 
penumbral failure. These ‘secondarily 
generalized’ seizures frequently involve 
loss of consciousness and convulsions, 
and they often represent the most 
disabling type of seizures for individuals 
with epilepsy. 
Inhibition
Because the propagation of seizures 
accounts for much of their morbidity, 
the mechanisms underlying inhibitory 
failure are the subject of intense 
investigation. Early evidence indicates 
that certain classes of inhibitory 
neurons essential for generation 
of the penumbra eventually enter 
depolarization block and abruptly cease 
fi ring at a time commensurate with 
propagation of the ictal wavefront. Other 
mechanisms accounting for inhibitory 
failure, including short-term changes in 
synaptic strength and shifts in key ionic 
gradients, are discussed below. 
Despite the multiple ways 
inhibition can fail, an obvious but 
profound clinical observation is that 
most seizures end spontaneously. 
Paradoxically, neuronal synchronization 
reaches its peak during the fi nal 
stages of a seizure, and seizures 
terminate abruptly over large areas 
of the brain. Several theories, many 
rooted in computational modeling of 
neural networks, have been advanced 
to account for these observations. 
Conceptually, seizures are sustained 
by progressive microcircuit recruitment 
and end once synchrony is suffi ciently 
pervasive that there are no neurons 
left to excite. This raises the intriguing 
possibilities that seizures which do not 
end spontaneously (status epilepticus) 
fail to reach a critical degree of 
synchrony, and that therapeutics that 
promote synchrony might actually 
facilitate seizure termination.
Transitions
The sudden and apparently stochastic 
nature of seizures is one of the most 
disabling features of epilepsy. The 
ability to predict seizures would 
be clinically useful in patients with 
epilepsy, improving safety, increasing 
independence, and allowing acute 
treatment. Large public databases 
of EEG recordings have facilitated 
the development of computational d
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Figure 3. Biological effects of genetic mutations associated with epilepsy.
Over 400 genes have been implicated in human epilepsy, and abnormal gene products can disrupt 
neural circuit function at various cell biological levels. Three genes thought to function at each 
level are shown to illustrate the diversity of epilepsy pathogenesis.algorithms for seizure prediction, 
and seizure advisory systems using 
implanted intracranial electrodes have 
been developed and tested in humans 
with promising results. Still, progress 
in our ability to predict seizures is 
hampered by our limited understanding 
of neurophysiological changes during 
the interictal-to-ictal transition.
How do normal levels of brain activity 
transform into the self-reinforcing, 
expanding patterns of excessive activity 
that characterize seizures? One idea is 
that the diverse genetic and acquired 
lesions that can cause epilepsy are 
unifi ed by disruption of neural circuit 
homeostasis. Given the centrality of 
inhibitory mechanisms in restraining 
seizure propagation, vulnerability to 
disinhibition may be important for seizure 
initiation as well. 
Synaptic plasticity — the ability of 
neurons to modulate the strength of 
their connections with other neurons 
as a function of activity — is essential 
for normal cognitive functions like 
learning and memory but may be 
maladaptive in some circumstances. 
For example, depending on the 
involved neurotransmitters and types 
of postsynaptic neurons, depression 
or facilitation of synaptic transmission 
could tip the balance between excitation 
and inhibition and promote initiation of 
seizures. Consistent with this, mutations 
in proteins subserving certain forms of 
synaptic plasticity have been associated 
with epilepsy. 
Another mechanism of activity-
dependent disinhibition at the 
cellular level is dysregulation of ionic 
conductances. The bulk of inhibitory 
neurotransmission in the brain is 
mediated by GABA receptors, but, during 
periods of prolonged activation, GABA 
receptors can become excitatory due 
to shifts in transmembrane gradients 
of bicarbonate and chloride. The 
endogenous mechanisms that normally 
avoid or counteract disinhibition and 
preserve homeostasis are incompletely 
understood, but some of our best clues 
come from studies of genetic epilepsies.
Genetics
The hereditary component of many 
epilepsies has been recognized since 
antiquity, but phenotypic complexity of 
epilepsy syndromes and technological 
barriers have limited our ability to identify 
specifi c genetic lesions. The advent Curof next generation DNA sequencing 
technology has facilitated exome and 
whole-genome sequencing, and large-
scale international collaborations have 
led to the discovery of genetic factors 
and mechanisms underlying many 
epilepsy syndromes. Indeed the term 
‘genetic’ has replaced ‘idiopathic’ in the 
classifi cation rubric of epilepsy.
Ion channels are critical for neuronal 
excitability and network stability, and 
heritable mutations in these molecules 
were among the fi rst genes identifi ed in 
association with epilepsy. For example, 
mutations in inhibitory GABA receptor 
subunit genes have been associated 
with a variety of epilepsy syndromes. 
Loss-of-function mutations in genes rent Biology 25, R733–R752, August 31, 201encoding subunits of excitatory sodium 
channel receptors (such as SCN1A) 
have also been identifi ed in severe 
childhood-onset epilepsies, and these 
mutations are thought to preferentially 
affect the function of inhibitory neurons. 
Other early-onset epilepsies are 
caused by loss-of-function mutations 
in KCNQ2/3 potassium channels, 
which mediate currents that modulate 
neuronal excitability and dampen the 
tendency for repetitive fi ring. 
Remarkably, most genetic mutations 
that have been associated with 
epilepsy do not involve genes encoding 
excitatory or inhibitory ion channels 
(Figure 3). For example, mutations in 
genes affecting the mTOR intracellular 5 ©2015 Elsevier Ltd All rights reserved R745
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is critical for metabolic sensing 
and neurite outgrowth, have been 
implicated in a variety of epilepsy 
syndromes, particularly those involving 
malformations of cortical development. 
Other genetic loci recently implicated 
in epilepsy include PCDH7, which 
encodes a neuronal cell–cell adhesion 
molecule implicated in synapse 
development, and QARS, a glutamine 
tRNA synthetase. These fi ndings 
highlight the power of a genetic 
approach to understanding disease 
pathogenesis, and they remind us 
that episodic, network-level electrical 
disturbances in epilepsy are ultimately 
rooted in cell biological mechanisms 
regulating network structure, function, 
and stability. 
Therapeutics
At the dawn of an era of precision 
medicine, the fi eld of epilepsy is 
well-positioned to play a leading role. 
Knowledge of the specifi c genetic 
lesion(s) underlying an epilepsy 
syndrome can inform choice of an 
antiepileptic drug. Retigabine, a 
potassium channel opener, is used 
to treat potassium channel KCNQ2/3 
epilepsies, and quinidine, a potassium 
channel blocker, has been shown to be 
effective in some patients with epilepsy 
caused by gain-of-function mutation in 
KCNT1 potassium channels. Sodium 
channel blockers are often avoided in 
Dravet syndrome and other epilepsies 
known to involve dysfunction of the 
sodium channel subunit SCN1A. 
Important advances have also been 
made in identifying genetic markers 
associated with side effects of 
antiepileptic drugs. 
The newest therapeutic avenue for 
patients with drug-resistant epilepsy 
is neurostimulation. In this approach, 
intracranial electrodes are implanted 
chronically, and defi ned patterns of 
electrical current are applied directly 
to the brain to modulate epileptogenic 
circuits. Neurostimulation is indicated in 
multifocal epilepsy and in cases where 
seizures arise from eloquent brain 
regions that cannot be safely resected. 
One device for neurostimulation, the 
Responsive Neurostimulation System 
(RNS System®; NeuroPace, Inc.), is 
currently approved for use in the United 
States. The RNS System functions in a 
closed-loop fashion, detecting incipient R746 Current Biology 25, R733–R752, Augusseizure activity with intracranial 
electrodes and counter-stimulating 
to terminate seizures via a small, 
programmable neurostimulator seated 
in the skull. 
A related but open-loop technology, 
deep brain (anterior thalamic nucleus) 
stimulation (DBS), has been approved 
in several countries and may soon be 
available in the United States. Compared 
to resective surgery, an attractive 
feature of RNS and DBS for epilepsy 
is that these are reversible treatments, 
and the implanted electrodes can be 
removed without signifi cant permanent 
alteration of brain structure. RNS has 
the additional advantage of recording 
and storing brain activity chronically in 
an ambulatory setting, which offers an 
unprecedented opportunity to study the 
longitudinal dynamics of the epileptic 
brain.
Another form of direct neural circuit 
modulation involves optogenetics, 
technology in which genetically-
encoded light-sensitive ion channels are 
introduced into defi ned populations of 
neurons whose fi ring activity can then 
be precisely controlled with light pulses. 
Optogenetics has already demonstrated 
immense experimental utility for 
deconstructing neural circuit function, 
and work in animal models of epilepsy 
suggests potential future therapeutic 
utility for treating seizures. 
Despite the availability of over 20 
antiepileptic drugs that inhibit seizures 
through action on a variety of molecular 
targets, an elusive goal in the fi eld has 
been the development of treatments 
that prevent epileptogenesis following 
cerebral insults like stroke or trauma. 
Inhibitors of the mTOR pathway are 
showing promise in this regard, but long-
term effects are not known. For patients 
with drug-resistant epilepsy arising from 
a single focus, surgical resection remains 
one of the most effective treatments, but 
it is likely that current practice involves 
removal of signifi cantly more brain tissue 
than is necessary to achieve seizure 
control. 
Thus, a major thrust of current research 
involves using advanced neuroimaging 
methods and electrophysiological 
biomarkers to defi ne the minimal 
seizure onset zone and enable more 
parsimonious surgical approaches. Other 
major challenges that lie ahead include 
unraveling the mechanisms of complex 
polygenic epilepsies and understanding t 31, 2015 ©2015 Elsevier Ltd All rights reservehow the neural circuit dysfunction that 
leads to seizures also predisposes 
individuals to cognitive impairment and 
psychiatric illness, both of which are 
frequently co-morbid with epilepsy.
Conclusion
Epilepsy pathogenesis involves neuronal 
dysfunction at genetic, cellular, and 
circuit levels. Technological advances 
have facilitated mechanistic discovery 
at each level and paved the way for 
novel therapeutic strategies. As the 
elements common to all seizures 
emerge, our appreciation for the 
heterogeneity of epilepsy biology grows. 
The challenges ahead are to integrate 
an ever-growing wealth of genetic data 
with an increasingly nuanced picture 
of seizure physiology and to leverage 
this knowledge to develop improved 
therapeutics.
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